Status:
COMPLETED
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Lead Sponsor:
Virdi Eye Clinic
Conditions:
Myopia
Eligibility:
All Genders
21+ years
Brief Summary
This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.
Eligibility Criteria
Inclusion
- male or female at least 18 years of age,
- no other ocular studies with 15 days prior to dosing,
- BCVA 20/200 or better,
- return for study visits and follow instructions from investigator and staff,
- self administer test article
Exclusion
- Ocular inflammation,
- hypersensitivity to bromfenac or nepafenac,
- any corneal pathology,
- have had radial keratotomy,
- corneal transplant or corneal refractive surgery in the last two years
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01475877
Start Date
May 1 2011
End Date
May 1 2012
Last Update
May 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virdi Eye Clinic and Laser Vision Center
Rock Island, Illinois, United States, 61201